vascular access for HD (2, 3). Unfortunately, AVFs have been associated with high failure rates, being reported at 30 to 50%, predominately due to aggressive pathological process termed venous intimal hyperplasia (VIH) (4, 5). Numerous factors have been described as having an effect on the success rate, and therefore a prognostic predictive model would be extremely important in planning in clinical practice for example guiding decisions on the site of the AVF (6). Existing reviews of prediction models in other diseases have shown that model design is critical and many models are poorly developed with weaknesses in their methodology, validation, and reporting (7).
Introduction
Predictive models, both diagnostic and prognostic, are tools that combine multiple predictors to obtain a risk or probability. They are becoming increasingly described in the medical literature and used in clinical practice. These models have considerable potential to contribute to the decision-making process regarding the management of a patient. Typically, they combine several clinical, investigational or patient-related measures to calculate the likelihood of an outcome.
Haemodialysis (HD) is a life-preserving therapy for patients with end-stage renal disease (ESRD). It is estimated that over 1.5 million patients receive regular HD treatment worldwide with the number growing at a rate of around 7% (1) . A critical factor in the survival of renal dialysis patients is the surgical creation of vascular access and international guidelines recommend arteriovenous fistulas (AVF) as the gold standard of Grey literature was not searched or included. The systematic review was performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines (8) .
Articles were included if they aimed to develop a multivariable prognostic predictive model for AVF maturation or patency outcomes. Articles were excluded if they did not develop a new model or the outcome was different from the inclusion criteria.
Two reviewers (JA and DM) independently identified articles and screened them for inclusion. Disagreements were solved by consensus between authors. Where this was not possible, a 3 rd opinion (NI) was sought. Eligible articles were used to develop a potential prognostic assessment tool for predicting patency of arteriovenous fistula at 1 year. Studies that assess causal effect of a predictor(s) without modelling were excluded.
From each study, we extracted data on study design, population, outcome definition, setting, demographics, the number of patients included, the number of variables tested as predictors, model development and evaluation, and the type of statistical model, using a data extraction sheet. Each study underwent assessment using the TRIPOD statement (9) .
results
A total of 1378 articles and abstracts were identified using our search strategy. After screening the contents of the abstract, 16 full text articles underwent assessment for eligibility and quality inspection of methodology ( Fig. 1 ). After the assessment, four articles were found to be eligible for the review (Tab. I). One paper proposed two different models and therefore a total of five models have been included in our study. Three models were developed using North American data from Canada (10) and the USA (11) and the other two models were from the UK (12, 13) . Of note, the two British papers only focused on one type of AVF each (radiocephalic and snuff box) (12, 13) (Tab. II).
The number of participants included in the development of the prediction models was clearly reported in all four studies, ranging from 218 to 422 patients. The prognostic predictive models included a median of five risk predictors. The most commonly identified risk predictors included age, venous diameter and CVD. Three models used multivariable regression model, whilst the other two models used a series of separate univariable Cox regression analyses. All studies clearly identified the type of statistical method that they used to derive the prediction model, two were derived using a Cox proportional hazards model (12, 13) and three models used logistic regression (10, 11) . All five studies claimed to have carried out some form of evaluation of the prediction model. Three models (10, 11) (60%) conducted an internal validation of the prediction model with bootstrapping, with one of them also using an internal cross validation and external validation (11) . In our opinion two studies did not sufficiently assess their models to validate them (12, 13) .
Three studies (11-13) (60%) derived simplified scoring systems from the risk prediction models. One study (11) derived a simple points system by rounding odds ratios to the nearest integer, whereby the resulting score would be a simple summation of the integers. One study (12) derived a simple scoring system by giving an integer of 1 for all significant variables; however, they did not actually use the hazard ratios from the Cox model. The second study (13) used a similar simple method; however decided to give two significant variables an integer of 2 due to their higher hazards ratio. Parameters identified that were common to all scoring system were age and cardiovascular disease (CVD). Recent studies have confirmed both age and CVD as a risk factor in VA outcomes, which supports both as potential prognostic markers (14) .
Previous access was identified as a risk factor in two studies and specifically contralateral previous access. Venous diameter, a major factor in access planning, was only noted in three models although studies assessing outcome using vein size less than a pre-defined threshold (e.g., <2 mm cephalic vein at wrist) show a strong correlation with failure (6) .
Dialysis dependency and blood pressure (BP) was noted in two studies. Whilst studies subdividing patients into predialysis and post-dialysis AVF formation show better outcomes for the former, this may be confounded by multiple factors such as previous access attempts, central venous catheters, uraemia and overall clinical co-morbidity (6) .
In access naïve patients, AVF outcome was no different from that in patients who had already started dialysis, although in patients where access was created on the ipsilateral side as a previous CVC had worse outcomes. This is consistent with previous access being a parameter.
Ethnicity, which has previously been shown to affect outcome, was only used in one study and may reflect the low level of ethnic diversity in the studies rather than a true reflection of ethnicity as a risk (11) .
Pre-existing disease (such as diabetes), was only a risk in one model although other markers of arterial disease (previous cerebrovascular accident/previous lower limb angioplasty/peripheral vascular disease) were used. The contribution of arterial factors to AVF outcome is poorly defined and more accurate measures may be required to enable inclusion in prognostic models.
One model used absent intra-operative thrill as a strong, but not unexpected, marker of negative outcome.
Discussion
Haemodialysis is a lifeline for end-stage renal failure patients, with vascular access being a major component of survival. AVFs have been described as the gold standard due to their potential long-term patency, decreased rate of complications such as infection and overall survival benefit (15) . Despite this, a major limitation of AVFs is the need for the vein to mature to a size large enough to be needled for haemodialysis. A number of factors have been associated with failure of maturation and these have been described widely in the current literature (6) . They include both patient and surgical variables.
In the general medical literature, scoring systems and predictive models have been widely recognised as useful tools in stratifying patients and predicting outcomes in cohorts of patients. In vascular access, the ability to predict successful maturation or high risk of failure to mature may allow tailoring of clinical practice to individual patients and allow better planning of procedure and improved success. In common with many areas of vascular access where the current literature has little evidence, there is a lack of available data on predictive models and this review could find only four eligible studies with a total of five models being described. This is a limitation to this review, although it does highlight a key area for future research. Only one paper was found to attempt to validate the available models and it would suggest that these are not widely used in clinical practice (16) . The lack of demonstration of validation and performance evaluation of these models on new populations makes it impossible to recommend them. Further testing and validation by a different group of investigators in different patient cohorts is necessary. More advanced statistical approaches such as boot strapping to internally validate the predictive model may be used.
A weakness of comparing these models is the heterogeneity of outcomes that were used in the available models, in particular AVF maturation, AVF non-maturation or AVF patency (10) (11) (12) (13) . This is a typical problem in studies of vascular access as different and often non-standardised outcomes are commonly described in different studies, making comparison challenging and recommendations for standard outcome measures is mandated (17) .
The number of patients involved in the modelling process in the identified studies (n = 218 to 422) compares poorly to available models on other topics such as end-stage renal failure where numerous models used over 5000 patients (7) . Compared to models used in other topics, those available to this review use few variables. The results of the haemodialysis fistula maturation study (18) will hopefully yield more data for predictive modelling with a higher number of patients and potentially more predictive variables.
In conclusion, this review has found a small number of predictive models in vascular access. The disparity between each study limits the development of a unified predictive model and therefore we recommend more research is required in this field. The utility of an accurate well-designed predictive model, which could be applicable to a clinical setting, would provide benefit in the planning and tailoring of vascular access for haemodialysis.
